Leveraging the Cancer Stem Cell Glycome to Identify Aggressive Tumor Populations in Breast Cancer
Intratumor heterogeneity poses a significant challenge for the diagnosis and treatment of patients with breast cancer because distinct sub-populations of tumor cells contribute significantly more to therapy resistance and tumor recurrence than others. Consequently, understanding the mechanisms that...
Main Author: | Walker, Melanie R. |
---|---|
Format: | Others |
Published: |
eScholarship@UMassChan
2021
|
Subjects: | |
Online Access: | https://escholarship.umassmed.edu/gsbs_diss/1159 https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2169&context=gsbs_diss |
Similar Items
-
Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting
by: Yuanyuan Li, et al.
Published: (2018-12-01) -
Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer
by: Shaheen Mahira, et al.
Published: (2019-02-01) -
Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer
by: Zhang W, et al.
Published: (2019-07-01) -
Targeting Aberrant Sialylation to Treat Cancer
by: Jennifer Munkley, et al.
Published: (2019-10-01) -
Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System
by: Tao Yu, et al.
Published: (2020-08-01)